ASHLEY TOLBERT: Open Payments
NPI 1366821449 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,999 in 103 payments from 19 companies in 2025. Trend: 2023 $910 · 2024 $1,960 · 2025 $1,999
Food & beverage: $1,999
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 34 | $543 |
| ABBVIE INC. | 22 | $421 |
| Neurocrine BioSciences, Inc. | 6 | $159 |
| ANI Pharmaceuticals, Inc. | 6 | $143 |
| MML US, Inc. | 2 | $95 |
| PFIZER INC. | 6 | $89 |
| Collegium Pharmaceutical, Inc. | 4 | $79 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| BIOTRONIK NRO, Inc. | 2 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $61 |
Products named: WaveWriter Alpha Prime 16, QULIPTA, INGREZZA, PURIFIED CORTROPHIN GEL, BOTOX, ReActiv8, Belbuca, UBRELVY.
Industry payments across IN — which companies pay providers there.
